Ablaze Pharmaceuticals
PrivateLast Round
Series A
Nov 29, 2021
Total Funding Raised
$75M
Company Overview
Ablaze Pharmaceuticals is a biopharmaceutical company specializing in the development of Targeted Radiotherapy (TRT) treatments for cancer patients in the Chinese market.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ablaze Pharmaceuticals Comparables
Compare Ablaze Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AlphaGen Therapeutics | 89% | |
| C-Ray Therapeutics | 88% | |
| Yantai Lannacheng Biotechnology Co., Ltd. | 84% | |
Ablaze Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 29, 2021 |
Key People
Founding team and executive leadership
Ablaze Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nan Fung Life Sciences | Series A |
| Advantech Capital | Series A |
| Nan Fung Group | Series A |
| venBio | Series A |
| Venrock | Series A |
| Samsara BioCapital | Series A |
| Vivo Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 29, 2021
$75M round led by Vivo Capital and Advantech Capital.
Ablaze Pharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ablaze Pharmaceuticals's valuation, stock price, and market status.